Last updated: November 22, 2023
Sponsor: University of California, Los Angeles
Overall Status: Completed
Phase
N/A
Condition
Hiv/aids
Treatment
HHMB
Clinical Study ID
NCT04025463
1U01HL142109
1U01HL142109
Ages > 18 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Organizational/Staff Eligibility
- Inclusion Criteria: staff employed by the participating agencies
Exclusion
- Exclusion Criteria: non-employees of the participating agencies Patient Eligibility
- Inclusion Criteria
- African American and Latino
- Patient cared for in a participating agency
- 18 to 60 years of age
- Living with HIV or AIDS
- Speak English or Spanish
- Screen greater than 0 on the UCLA Life Adversities Screener (LADS)
- Identify at least one self-reported CVD risk factor
- Exclusion Criteria - Potential participants will be screened by the ProjectCoordinator, who will be trained to assess the following exclusion criteria:
- Known psychiatric, physical or neurological impairment that would limit theireffective participation;
- Recent history of a severe illness, sexual or physical abuse that might requiresudden medical, psychological and/or legal intervention
- Unwilling or unable to give consent or to commit to participate in the studythrough completion.
Study Design
Total Participants: 202
Treatment Group(s): 1
Primary Treatment: HHMB
Phase:
Study Start date:
October 01, 2019
Estimated Completion Date:
May 31, 2023
Study Description
Connect with a study center
OASIS Clinic
Los Angeles, California 90059
United StatesSite Not Available
Northeast Valley Healthcare Corporation
Van Nuys, California 91405
United StatesSite Not Available


Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.